Master’s studies

Molecular Imaging with Focus on PET 2018/2019 (7.5 credits)

Autumn 2018 weeks 45-49 - 100 % - Campus

Application Deadline: 2018-04-16

Enrolment Code: UU-35012 Application

Language of Instruction: English

Location: Uppsala

Selection: Higher education credits (maximum 285 credits)

Spring 2019 weeks 13-18 - 100 % - Campus

Application Deadline: 2018-10-15

Enrolment Code: UU-85012 Application

Language of Instruction: English

Location: Uppsala

Selection: Higher education credits (maximum 285 credits)

Entry Requirements: For elective course, semester 8, within the pharmacy programme is required 150 credits within the program, of which 60 credits chemistry or 60 credits bioscience. For students within the biomedicine and the physician programmes and for student within the Bachelor's programmes in molecular biology or biotechnology, 135 credits within the programme including 60 credits biology are required. Students who are admitted to the Master's programme in drug development are qualified to read the course. Other education is assessed individually. Knowledge in English equivalent what is required for general entry claims to Swedish first-cycle programmes.

Fees:

If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application or tuition fees. Formal exchange students will be exempted from tuition fees, as well as the application fee. Read more about fees.

Application Fee: SEK 900

Tuition fee, first semester: SEK 18125

Tuition fee, total: SEK 18125

About the course:

Molecular imaging (MI) is essentially a multidisciplinary field. For deeper understanding of the method, it is required that the course illustrates all parts of the process from the physics behind the instruments to radio- labelling of molecules validation of these in vitro and in vivo.. The course will also exemplify the questions which are suitable answered by MI. The course covers radiochemistry in tracer development, preclinical methods for in vitro validation of molecular traces, preclinical in vivo imaging using PET and SPECT tracers, image analysis and image processing tools, quantification and modelling of tracer kinetics, PET, PET as a tool for drug development and the clinical use of PET, e.g. within neurology, oncology, cardiology, metabolic diseases and psychiatry.  

More information

Contact

Department of Medicinal Chemistry

Uppsala Biomedicinska Centrum BMC, Husarg. 3

Box 574, 751 23 UPPSALA

Telephone: 018-471 4271